Stock Updates

Is this Large Market Cap Stock target price reasonable for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)?

The company in question is, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) currently with a stock price of 13.88 (-1.63% today). The market cap for Ironwood Pharmaceuticals, Inc. is 2047.78, and is in the sector Healthcare, and Drugs РGeneric industry. The target price for Ironwood Pharmaceuticals, Inc. is 15. Currently Ironwood Pharmaceuticals, Inc. is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Ironwood Pharmaceuticals, Inc. is 1190.55 and so far today it is 540488.

Performance in the last year for Ironwood Pharmaceuticals, Inc. has been 30.17%. For EPS growth, Ironwood Pharmaceuticals, Inc. has seen a growth of 27.60%, and is looking to grow in the next year to 40.00%. More long term stats show that EPS growth has been -9.80% over the last five years and could be 39.00% for the next five years. Ironwood Pharmaceuticals, Inc. has seen sales growth quarter over quarter at 96.40%, with EPS growth quarter over quarter at 55.60%. The 20-day simple moving average is -3.48%, with the 200-day simple moving average coming to 15.53%.

Since the IPO date for Ironwood Pharmaceuticals, Inc. on the 02/03/2010, Ironwood Pharmaceuticals, Inc. has seen performance year to date to be 21.74%. With Ironwood Pharmaceuticals, Inc. trading at 13.88, the dividend yield is *TBA, and the EPS is -0.67.

So could Ironwood Pharmaceuticals, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 9.6 and the P/B is at 25.2. The P/cash is 6.3, with P/free cash flow at *TBA.

Ironwood Pharmaceuticals, Inc. ability to deal with debt shows that the current ratio is 4.2, and the quick ratio is *TBA. This is with long term debt/equity at 4.17, and total debt/equity at 4.63.

In terms of margins, Ironwood Pharmaceuticals, Inc. has a gross margin of *TBA, an operating margin of -23.10% and a profit margin of -45.20%.Payout ratio for Ironwood Pharmaceuticals, Inc. is *TBA. Return on assets come to -15.20% with return on investment coming to *TBA.

Insider ownership for Ironwood Pharmaceuticals, Inc., is at 0.50% and institutional ownership comes to *TBA. Outstanding shares are at 145.13. While shares float is 129.29. The float short is currently 10.66%, and short ratio is 11.58.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment